0000000000014480

AUTHOR

Azzolina A

Cationic Solid-lipid nanoparticles as DNA carriers.

research product

Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells

research product

Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells

research product

Influence of MEK/ERK signaling on apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells

research product

Solid-lipid nanoparticles for gene delivery to cells.

research product

Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells

research product

Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response

research product

Inhibition of the MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells

research product

Cationic solid-lipid nanoparticles for gene delivery.

research product

The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells

research product

Antitumor effects of the selective cycloxygenase-1 inhibitor SC-560 is potentiated by inhibition of MEK/ERK pathway in human hepatocellular cells.

research product